|
[1]
|
Xia, W., Lau, Y.K., Zhang, H.-Z., Xiao, F.-Y., Johnston, D.A., Liu, L., Katz, R.L. and Hung, M.-C. (1999) Combination of EGFR, HER-2/Neu and HER-3 Is a Stronger Predicator for Outcome of Oral Squamous Cell Carcinoma than Any Individual Family Members. Clinical Cancer Research, 5, 4164-4174.
|
|
[2]
|
Ching, S., Low, I., Ng, D., Brasch, H., Sullivan, M., Davis, P. and Tan, S.T. (2008) Epidermal Growth Factor Receptor: A Novel Biomarker for Aggressive Head and Neck Cutaneous Squamous Cell Carci-
noma. Human Pathology, 39, 344-349. http://dx.doi.org/10.1016/j.humpath.2007.07.004
|
|
[3]
|
Thomas, L., Moore, E.J., McGree, M.E., Olsen, K.D., Kasperbauer, J.L., Erickson, L.A. and Schembri-Wismayer, D.J. (2012) Prognostic Features, Human Papillomavirus Status and Epidermal Growth Receptor Expression in Oral Squamous Cell Carcinoma in Young Adults. American Journal of Otola-
ryngology, 33, 650-656.
http://dx.doi.org/10.1016/j.amjoto.2012.01.009
|
|
[4]
|
Cripps, C., Winquist, E., Devries, M.C., Stys-Norman, D. and Gilbert, R. (2010) Epidermal Growth Factor Receptor Targeted Therapy in Stages II and IV Head and Neck Cancer. Current Oncology, 17, 37-48.
http://dx.doi.org/10.3747/co.v17i3.520
|
|
[5]
|
Goffin, J.R. and Zbuk, K. (2013) Epidermal Growth Factor Receptor: Pathways, Therapies and Pipeline. Clinical Therapeutics, 9, 1282-1303. http://dx.doi.org/10.1016/j.clinthera.2013.08.007
|
|
[6]
|
Carpenter, G. (1987) Receptors for Epidermal Growth Factor and Other Polypeptide Mitogens. Annual Review of Biochemistry, 56, 881-914. http://dx.doi.org/10.1146/annurev.bi.56.070187.004313
|
|
[7]
|
Kelloff, G.J., Fay, J.R., Steele, V.E., Lubet, R.A., Boone, C.W. and Crowell, J.A. (1996) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Potential Cancer Chemopreventives. Cancer Epidemiology, Biomarkers & Prevention, 5, 657-666.
|
|
[8]
|
Yewale, C., Baradia, D., Vhora, I., Patil, S. and Misra, A. (2013) Epidermal Growth Factor Receptor: Targeting in Cancer: A Review of Trends and Strategies. Biomaterials, 34, 8690-8707.
http://dx.doi.org/10.1016/j.biomaterials.2013.07.100
|
|
[9]
|
Pastore, S., Mascia, F., Mariani, V. and Girolomoni, G. (2007) The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation. The Society for Investigative Dermatology, 128, 1365-1374.
http://dx.doi.org/10.1038/sj.jid.5701184
|
|
[10]
|
Schneider, M.R. and Wolf, E. (2009) The Epidermal Growth Factor Receptor Ligands at a Glance. Journal of Cellular Physiology, 218, 460-466. http://dx.doi.org/10.1002/jcp.21635
|
|
[11]
|
Higashiyama, S., Iwabuki, H., Morimoto, C., Hieda, M., Inoue, H. and Matsushita, N. (2008) Membrane-Anchored Growth Factors, the Epidermal Growth Factor Family: Beyond Receptor Ligands. Cancer Science, 99, 214-220.
http://dx.doi.org/10.1111/j.1349-7006.2007.00676.x
|
|
[12]
|
Konda, Y., Yokota, H., Kayo, T., Horiuchi, T., Sugiyama, N., Tanaka, S., Takata, K. and Takeuchi, T. (1997) Proprotein-Processing Endoprotease Furin Controls the Growth and Differentiation of Gastric Surfaces Mucous Cells. Journal of Clinical Investigation, 99, 1842-1851.
http://dx.doi.org/10.1172/JCI119351
|
|
[13]
|
Schwartz, J., Izaquirre, G., Pavlova, S., Sroussi, H., Lu, Y., Munaretto, A., Crowe, D. and Tao, L. (2014) Alcohol Treatment of Oral Streptococcus spp. Increased the Entry of Human Papillomvirus Type 16 into Non-Malignant and Oral Squamous Cell Carcinoma Cells. Journal of Oral Biology, 1, 12.
|
|
[14]
|
Nakatani, Y., Yamazaki, M., Chazin, W.J. and Yui, S. (2005) Regulation of S100A8/A9 (Calprotectin) Binding to Tumor Cells by Zinc Ion and Its Implication for Apoptosis—Inducing Activity. Mediators of Inflammation, 5, 280-292.
http://dx.doi.org/10.1155/MI.2005.280
|
|
[15]
|
Donate, R., Cannon, B.R., Sorci, G., Riuzzi, F., Hsu, K., Weber, D.J. and Geczy, C.L. (2013) Functions of S100 Proteins. Current Molecular Medicine, 13, 24-57.
http://dx.doi.org/10.2174/156652413804486214
|
|
[16]
|
Inki, P., Joensuu, H., Grenman, R., Klemi, P. and Jalkanen, M. (1994) Association between Syndecan-1 Expression and Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck. British Journal of Cancer, 70, 319-323.
http://dx.doi.org/10.1038/bjc.1994.300
|
|
[17]
|
Omar, A.A.H., Haglund, C., Virolainen, S., Hayry, V., Atula, T., Kontio, R., Rihtniemi, J., Pihakari, A., Salo, T., Hagstrom, J. and Sorsa, T. (2013) Epithelial and Stromal Syndecan-1 and -2 Are Distinctly Expressed in Oral and Cutaneous Squamous Cell Carcinomas. Journal of Oral Pathology & Medicine, 42, 389-395.
http://dx.doi.org/10.1111/jop.12025
|
|
[18]
|
Kerkoff, C., Nacken, W., Benedyk, M., Dagher, N.C., Sopalla, C. and Doussiere, J. (2005) The Arachidonic Acid-Binding Protein S100 A8/A9 Promotes NADPH Oxidase Activation by Interaction with p67phox and Rac-2. The FASEB Journal. http://dx.doi.org/10.1096/fj.04-2377fje
|
|
[19]
|
Blobel, C.P. (2005) ADAMS: Key Components in EGFR Signaling and Development. Nature, 6, 32-43.
|
|
[20]
|
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C.G., Docherty, A.J.P., Lambert, M., Skelton, L., Jockusch, H. and Bartsch, J.W. (2002) The Metalloprotease Disintegrin ADAM8. Journal of Biological Chemistry, 277, 48210-48219.
http://dx.doi.org/10.1074/jbc.M203355200
|
|
[21]
|
Abe, Y., Odaka, M., Inagaki, F., Lax, I., Schlessinger, J. and Kohda, D. (1998) Disulfide Bond Structure of Human Epidermal Growth Factor Receptor. The Journal of Biological Chemistry, 273, 11150-11157.
http://dx.doi.org/10.1074/jbc.273.18.11150
|
|
[22]
|
Bassi, D.E., De Cicco, R.C., Mahloogi, H., Zucker, S., Thomas, G. and Klein-Szanto, A.J.P. (2001) Furin Inhibition Results in Absent or Decreased Invasiness and Tumorigenicity of Human Cancer Cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 10326-10331. http://dx.doi.org/10.1073/pnas.191199198
|
|
[23]
|
Seidah, N.G. (2011) What Lies Ahead for the Proprotein Convertase? Annals of the New York Academy of Sciences, 1220, 149-161. http://dx.doi.org/10.1111/j.1749-6632.2010.05883.x
|
|
[24]
|
Bassi, D.E., De Cicco, R.C. and Klein-Szanto, A.J.P. (2005) Proprotein Convertases: “Master Switches” in the Regulation of Tumor Growth and Progression. Molecular Carcinogenesis, 44, 151-161.
http://dx.doi.org/10.1002/mc.20134
|
|
[25]
|
Vidricaire, G., Denault, J.B. and Leduc, R. (1993) Characterization of a Secreted form of Human Furin Endoprotease. Biochemical and Biophysical Communications, 195, 1011-1018.
http://dx.doi.org/10.1006/bbrc.1993.2145
|
|
[26]
|
Roebroek, A.J., Schalken, J.A., Leunissen, J.A., Onnekink, C., Bloemers, H.P. and Van de Ven, W.J. (1986) Evolutionary Conserved Close Linkage of the C-fes/fps Proto-Oncogene and Genetic Sequences Encoding a Receptor-Like Protein. The EMBO Journal, 16, 4938-4950.
|
|
[27]
|
Roghani, M., Becherer, J.D., Moss, M.L., Atherton, R.E., Erdjument-Bromage, H., Arribas, J., Blackburn, R.K., Weskamp, G., Temst, P. and Blobel, C.P. (1999) Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity. The Journal of Biological Chemistry, 272, 3531-3540.
http://dx.doi.org/10.1074/jbc.274.6.3531
|
|
[28]
|
Wolf, E. (2009) The Epidermal Growth Factor Receptor Ligands at a Glance. Journal of Cellular Physiology, 218, 460-466. http://dx.doi.org/10.1002/jcp.21635
|
|
[29]
|
Kwak, K., Jiang, R., Wang, J.W., Jagu, S., Kirnbauer, R. and Roden, R.B.S. (2014) Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types. PLoS ONE, 9, 1-11.
http://dx.doi.org/10.1371/journal.pone.0097232
|
|
[30]
|
Day, P.M. and Schiller, J.T. (2009) The Role of Furin in Papillomavirus Infection. Future Microbiology, 4, 1255-1262.
http://dx.doi.org/10.2217/fmb.09.86
|
|
[31]
|
Richards, R.M., Lowy, D.R., Schiller, J.T. and Day, P.M. (2006) Cleavage of the Papillomavirus Minor Capsid Protein L2 at a Furin Consensus Site Is Necessary for Infection. Proceedings of the National Academy of Sciences of the United States of America, 103, 1522-1527.
http://dx.doi.org/10.1073/pnas.0508815103
|
|
[32]
|
Lokman, N.A., Ween, M.P., Oehler, M.K. and Ricciardelli, C. (2011) The Role of Annexin A2 in Tumorigenesis and Cancer Progression. Cancer Microenvironment, 4, 199-208.
http://dx.doi.org/10.1007/s12307-011-0064-9
|
|
[33]
|
Raff, A.B., Woodham, A.W., Raff, L.M., Skeate, J.G., Yan, L., Da Silva, D.M., Schelhaas, M. and Kast, W.M. (2013) The Evolving Field of Human Papillomavirus Receptor Research: A Review of Binding and Entry. Journal of Virology, 87, 6062-6072. http://dx.doi.org/10.1128/JVI.00330-13
|
|
[34]
|
Sketty, P.K., Thake, S.I., Biswas, S., Johansson, S.L. and Vishwanatha, J.K. (2012) Reciprocal of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin—Resistant Breast Cancer. PLoS ONE, 7, e44299.
http://dx.doi.org/10.1371/journal.pone.0044299
|
|
[35]
|
Mistry, N., Wibom, C. and Evander, M. (2008) Cutaneous and Mucosal Human Papillomaviruses Differ in Net Surface Charge, Potential Impact on Tropism. Virology Journal, 5,118-126.
http://dx.doi.org/10.1186/1743-422X-5-118
|
|
[36]
|
Ishii, Y., Makahara, T., Kataoka, M., Kusumoto-Matsuo, R., Mori, S., Takeuchi, T. and Kukimoto, I. (2013) Identification of TRAPPC8 as a Host Factor Required for Human Papillomavirus Cell Entry. PLoS ONE, 8, e80297.
|
|
[37]
|
Yunta, M. and Lazo, P.A. (2003) Tetraspanin Proteins as Organizers of Membrane Microdomains and Signaling Complexes. Cellular Signalling, 15, 559-564.
http://dx.doi.org/10.1016/S0898-6568(02)00147-X
|
|
[38]
|
Truong, T.H. and Carroll, K.S. (2012) Redox Regulation of EGFR Signaling through Cysteine Oxidation. Biochemistry, 51, 9954-9965.
http://dx.doi.org/10.1021/bi301441e
|
|
[39]
|
Zakhari, S. (2013) Alcohol Metabolism and Epigenetics Changes. Alcohol Research, 35, 6-16.
|
|
[40]
|
Hoffman, A.C. and Evans, S.E. (2013) Abuse Potential of Non-Nicotine Tobacco Smoke Components: Acetaldehyde, Nornicotine, Cotinine, and Anabasine. Nicotine Tobacco Research, 15, 622-632.
http://dx.doi.org/10.1093/ntr/nts192
|
|
[41]
|
Meurman, J.K. (2010) Oral Microbiota and Cancer. Journal of Oral Microbiology, 2, 5195.
|
|
[42]
|
Vitale-Cross, L., Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A.A. and Gutkind, J.S. (2009) Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer. Cancer Prevention Research, 2, 419-422.
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0058
|
|
[43]
|
Kupferman, M.E. and Myers, J.N. (2006) Molecular Biology of Oral Cavity Squamous Cell Carcinoma. Otolaryngologic Clinics of North America, 39, 229-247. http://dx.doi.org/10.1016/j.otc.2005.11.003
|
|
[44]
|
Husain, Q. and Qayyum, S. (2013) Biological and Enzymatic Treatment of Bisphenol A and Other Endocrine Disrupting Compounds: A Review. Critical Reviews in Biotechnology, 33, 260-292.
|
|
[45]
|
Zhang, L., Jin, Y., Huang, M. and Penning, T.M. (2012) The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones. Frontiers in Pharmacology, 16, 193.
|
|
[46]
|
Yokoyama, A. and Omori, T. (2005) Genetic Polymorphisms of Alcohol and Aldehyde Dehydrogenase and Risk for Esophageal and Head and Neck Cancers. Alcohol, 35, 175-185.
http://dx.doi.org/10.1016/j.alcohol.2005.04.003
|
|
[47]
|
Lieber, C.S. (1987) Metabolic Effects of Acetaldehyde. Biochemical Society Transactions, 16, 241-247.
|
|
[48]
|
Avezvov, K., Resnick, A.Z. and Aizenbud, D. (2014) Oxidative Damage in Keratinocytes Exposed to Cigarette Smoke and Aldehydes. Toxicology in Vitro, 28, 485-491.
http://dx.doi.org/10.1016/j.tiv.2014.01.004
|
|
[49]
|
Fenech, M. (2000) The in Vitro Micronucleus Technique. Mutation Research, 455, 81-95.
http://dx.doi.org/10.1016/S0027-5107(00)00065-8
|
|
[50]
|
Schwartz, J., Pavlova, S., Kolokythas, A., Lugakingira, M., Tao, L. and Miloro, M. (2012) Streptococci-Human Papilloma Virus Interaction with Ethanol Exposure Leads to Keratinocyte Damage. Journal of Oral and Maxillofacial Surgery, 70, 1867-1879. http://dx.doi.org/10.1016/j.joms.2011.08.005
|
|
[51]
|
Buck, C.B., Thompson, C.D., Roberts, J.N., Müller, M., Lowy, D.R. and Schiller, J.T. (2006) Carrageenan Is a Potent Inhibitor of Papillomavirus Infection. PLoS Pathogens, 2, e69.
http://dx.doi.org/10.1371/journal.ppat.0020069
|
|
[52]
|
Buck, C.B., Pastrana, D.V., Lowy, D.R. and Schiller, J.T. (2004) Efficient Intracellular Assembly of Papillomaviral Vectors. Journal of Virology, 78, 751-757.
http://dx.doi.org/10.1128/JVI.78.2.751-757.2004
|
|
[53]
|
Buck, C.B., Thompson, C.D., Pang, Y.Y., Lowy, D.R. and Schiller, J.T. (2005) Maturation of Papillomavirus Capsids. Journal of Virology, 79, 2839-2846.
http://dx.doi.org/10.1128/JVI.79.5.2839-2846.2005
|
|
[54]
|
Clemens, D.L., Calisto, L.E., Sorrell, M.F. and Tuma, D.J. (2003) Ethanol Metabolism Results in a G2/M Cell-Cycle Arrest in Recombinant Hep G2 Cells. Hepatology, 38, 385-393.
http://dx.doi.org/10.1053/jhep.2003.50332
|
|
[55]
|
Sheppard, K.E. and McArthur, G.A. (2013) The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma. Clinical Cancer Research, 19, 5320-5328.
http://dx.doi.org/10.1158/1078-0432.CCR-13-0259
|
|
[56]
|
Chen, K.M., Guttenplan, J.B., Zhang, S.M., Aliaga, C., Cooper, T.K., Sun, Y.W., Del Tondo, J., Kosinska, W., Sharma, A.K., Jiang, K., Bruggeman, R., Ahn, K., Amin, S. and El-Bayoumy, K. (2013) Mechanisms of Oral Carcinogenesis Induced by Dibenzo[a,l]pyrene: An Environmental Pollutant and a Tobacco Smoke Constituent. International Journal of Cancer, 133, 1300-1309.
http://dx.doi.org/10.1002/ijc.28152
|
|
[57]
|
Paye, A., Truong, A., Yip, C., Jonathan, C., Blacher, S., Munaut, C., Catado, D., Foidart, J.M., Maquoi, E., Collignon, J., Delvenne, P., Jerusalem, G., Noel, A. and Sounni, N.E. (2014) EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research, 74, 6758-6770.
|
|
[58]
|
Wei, W., Chen, Z.J., Zhang, K.S., Yang, X.L., Wu, Y.M., Chen, X.H., Huang, H.B., Liu, H.L., Cai, S.H., Du, J. and Wang, H.S. (2014) The Activation of G Protein-Coupled Receptor 30 (GPR30) Inhibits Proliferation of Estrogen Receptor-Negative Breast Cancer Cells in Vitro and in Vivo. Cell Death Disease, 5, e1428.
|
|
[59]
|
Song, W., Dang, Q., Xu, D., Chen, Y., Zhu, G., Wu, K., Zeng, J., Long, Q., Wang, X., He, D. and Li, L. (2014) Kaempferol Induces Cell Cycle Arrest and Apoptosis in Renal Cell Carcinoma through EGFR/p38 Signaling. Oncology Reports, 31, 1350-1356. http://dx.doi.org/10.3892/or.2014.2965
|
|
[60]
|
Huang, C.Y., Lin, H.J., Chen, H.S., Cheng, S.Y., Hsu, H.C. and Tang, C.H. (2013) Thrombin Promotes Matrix Metalloproteinase-13 Expression through the PKCδ/c-Src/EGFR/PI3K/Akt/AP-1 Signaling Pathway in Human Chondrocytes. Mediators of Inflammation, 2013, 1-12.
http://dx.doi.org/10.1155/2013/326041
|
|
[61]
|
Ohshiro, K., Bui-Nguyen, T.M., Divijendra Natha, R.S., Schwartz, A.M., Levine, P. and Kumar, R. (2012) Thrombin Stimulation of Inflammatory Breast Cancer Cells Leads to Aggressiveness via the EGFR-PAR1-Pak1 Pathway. The International Journal of Biological Markers, 27, e305-e313.
http://dx.doi.org/10.5301/JBM.2012.10437
|
|
[62]
|
Ribeiro, F.A., Noguti, J., Oshima, C.T. and Ribeiro, D.A. (2014) Effective Targeting of the Epidermal Growth Factor Receptor (EGFR) for Treatment of Oral Cancer: A Promising Approach. Anticancer Research, 34, 1547-1552.
|
|
[63]
|
Cohen, R.B. (2014) Current Challenges and Clinical Investigations of Epidermal Growth Factor Receptor (EGFR) and ErbB Family-Targeted Agents in the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Cancer Treatment Reviews, 40, 567-577.
http://dx.doi.org/10.1016/j.ctrv.2013.10.002
|
|
[64]
|
Baumeister, P., Heinrich, K., Märte, M., Reiter, M., Schwenk-Zieger, S. and Harréus, U. (2011) The Impact of EGFR Stimulation and Inhibition on BPDE Induced DNA Fragmentation in Oral/Oro-
pharyngeal Mucosa in Vitro. Oral Oncology, 47, 1141-1147.
http://dx.doi.org/10.1016/j.oraloncology.2011.08.006
|
|
[65]
|
Sun, Z., Sood, S., Li, N., Yang, P., Newman, R.A., Yang, C.S. and Chen, X. (2008) Chemoprevention of 7,12-Dimethylbenz[a]anthracene (DMBA)-Induced Oral Carcinogenesis in Hamster Cheek Pouch by Topical Application of a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and ErbB2 Tyrosine Kinases. Oral Oncology, 44, 652-657. http://dx.doi.org/10.1016/j.oraloncology.2007.08.006
|
|
[66]
|
Pogorzelski, M., Ting, S., Gauler, T.C., Breitenbuecher, F., Vossebein, I., Hoffarth, S., Markowetz, J., Lang, S., Bergmann, C., Brandau, S., Jawad, J.A., Schmid, K.W., Schuler, M. and Kasper, S. (2014) Impact of Human Papilloma Virus Infection on the Response of Head and Neck Cancers to Anti-Epidermal Growth Factor Receptor Antibody Therapy. Cell Death Disease, 5, e1091.
http://dx.doi.org/10.1038/cddis.2014.62
|
|
[67]
|
Mirghani, H., Amen, F., Moreau, F., Guigay, J., Hartl, D.M. and St Guily, J.L. (2014) Oropharyngeal Cancers: Relationship between Epidermal Growth Factor Receptor Alterations and Human Papillomavirus Status. European Journal of Cancer, 50, 1100-1111.
http://dx.doi.org/10.1016/j.ejca.2013.12.018
|
|
[68]
|
Surviladze, Z., Sterk, R.T., De Haro, S.A. and Ozbun, M.A. (2013) Cellular Entry of Human Papillomavirus Type 16 Involves Activation of the Phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and Inhibition of Autophagy. Journal of Virology, 87, 2508-2517.
http://dx.doi.org/10.1128/JVI.02319-12
|
|
[69]
|
Woodworth, C.D., Diefendorf, L.P., Jette, D.F., Mohammed, A., Moses, M.A., Searleman, S.A., Stevens, D.A., Wilton, K.M. and Mondal, S. (2011) Inhibition of the Epidermal Growth Factor Receptor by Erlotinib Prevents Immortalization of Human Cervical Cells by Human Papillomavirus Type 16. Virology, 421, 19-27.
http://dx.doi.org/10.1016/j.virol.2011.09.014
|
|
[70]
|
Kwak, K., Jiang, R., Wang, J.W., Jagu, S., Kirnbauer, R. and Roden, R.B.S. (2014) Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types. PLoS ONE, 9, e97232.
http://dx.doi.org/10.1371/journal.pone.0097232
|